Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland

British Journal of Dermatology

Volumn 161, Issue 1, 2009, Pages 56-62

  MacKintosh, L J ^a,b   De Koning, M N C ^c   Quint, W G V ^c   Ter Schegget, J ^c   Morgan, I M ^a   Herd, R M ^b   Campo, M S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c DDL DIAGNOSTIC LABORATORY   (Netherlands)

Author keywords

Human papillomaviruses; Immunosuppression; Nonmelanoma skin cancer; Organ transplantation; Polymerase chain reaction reverse hybridization assay

Indexed keywords

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; FEMALE; GENOTYPE; GRAFT RECIPIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 15; HUMAN PAPILLOMAVIRUS TYPE 24; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INTRAEPIDERMAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NONMELANOMA SKIN CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE HYBRIDIZATION ASSAY; SKIN BIOPSY; SKIN CANCER; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; UNITED KINGDOM; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

AGED; BETAPAPILLOMAVIRUS; FEMALE; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SCOTLAND; SKIN NEOPLASMS;

EID: 67649946108     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09146.x     Document Type: Article

References (30)

1. Stern RS. The mysteries of geographic variability in nonmelanoma skin cancer incidence. Arch Dermatol 1999 135 : 843 4.
2. MacKie RM. Long-term health risk to the skin of ultraviolet radiation. Prog Biophys Mol Biol 2006 92 : 92 6.
3. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours post transplantation: a retrospective analysis of 28 years' experience at a single center. Transplant Proc 1997 29 : 828 30.
4. Bouwes Bavinck JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996 61 : 715 21.
5. Jablonska S, Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr Top Microbiol Immunol 1994 186 : 157 75.
6. Orth G. Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. Ciba Found Symp 1984 120 : 157 74.
7. de Villiers EM, Fauquet C, Broker HUB, zur Hausen H. Classification of papillomaviruses. Virology 2004 324 : 17 27. (Pubitemid 38737395)
8. de Koning M, Quint W, Stuijk L et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridisation assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006 44 : 1792 800.
9. IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 90. Human Papillomaviruses. Lyon : IARC, 2007.
10. Bouwes Bavinck JN, Stark S, Petridis AK et al. The presence of antibodies against virus-like particles of epidermodysplasia verruciformis-associated human papillomavirus type 8 in patients with actinic keratoses. Br J Dermatol 2000 142 : 103 9.
11. Harwood CA, Surentheran T, Sasieni P et al. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus skin types in normal skin. Br J Dermatol 2004 150 : 949 57.
12. Steger G, Olszewsky M, Stockfleth E, Pfister H. Prevalence of antibodies to human papillomavirus type 8 in human sera. J Virol 1990 64 : 4399 406.
13. Feltkamp MCW, Broer R, di Summa FM et al. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer. Cancer Res 2003 63 : 2695 700.
14. Berkhout RJM, Bouwes Bavinck JN, ter Schegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000 38 : 2087 96.
15. Hartevelt MM, Bavinck JN, Kootte AMM et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990 49 : 506 9.
16. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999 40 : 177 86.
17. Lindelof B, Sigurgeirsson B, Gäbel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000 143 : 513 19.
18. Winkelhorst JT, Brokelman WJ, Tiggeler RG, Wobbes T. Incidence and clinical course of de-novo malignancies in renal allograft recipients. Eur J Surg Oncol 2001 27 : 409 13.
19. Hojo M, Morimoto T, Maluccio M et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999 397 : 530 4.
20. Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases. Cancer 1996 58 : 611 16.
21. Sheil AGR, Flavel S, Disney APS et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc 1987 19 : 2214 16.
22. Birkeland SA, Storm HH, Lamm LU et al. Cancer risk after renal transplantation in Nordic countries. Int J Cancer 1995 60 : 183 9.
23. de Carlis L, Slim AO, de Gasperi A et al. Posttransplant lymphoproliferative disorders: report from a single center. Transplant Proc 2001 33 : 2815 16.
24. Forslund O, Iftner T, Andersson K et al. Cutaneous human papillomaviruses found in sun-exposed skin: beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Invest Dermatol 2007 196 : 876 83.
25. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003 31 : 52 6.
26. Hopfl R, Bens G, Wieland U et al. Human papillomavirus DNA in non-melanoma skin cancers of a renal transplant recipient: detection of a new sequence related to epidermodysplasia verruciformis associated types. J Invest Dermatol 1997 108 : 53 6.
27. de Villiers EM, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997 73 : 356 61.
28. Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000 61 : 289 97.
29. Pfister H, Fuchs PG, Majewski S et al. High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population. Arch Dermatol Res 2003 295 : 273 9.
30. de Jong-Tieben LM, Berkhout RJ, Smits HL et al. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995 105 : 367 71.